B2M and cancer: There is plenty of research studies that have proved the efficiency of cell cycle-targeted cancer therapy recently.[30] In this study, twenty DEGs including CXCL10, CD44, B2M, XRCC5, PTPN11, and RPL11 were identified as hub genes for LA-NPC metastasis.